Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae

This publication has 139 references indexed in Scilit:

• Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage
  JAMA, 2007
• The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence
  Vaccine, 2006
• Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction Into Routine Childhood Immunization in Kenya
  JAMA, 2006
• Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens
  Vaccine, 2006
• Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination
  American Journal of Epidemiology, 2005
• Streptococcus pneumoniae colonisation: the key to pneumococcal disease
  The Lancet Infectious Diseases, 2004
• Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil
  International Journal of Epidemiology, 2004
• Meningococcal meningitis in Africa
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999
• Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children
  The Journal of Pediatrics, 1994
• Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy
  New England Journal of Medicine, 1987